Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Lansoprazole

SKU: orb1310397

Description

Lansoprazole is a timoprazole-derived proton pump inhibitor used to treat gastric ulcers and Zollinger-Ellison syndrome by inhibiting H+/K+-ATPase in parietal cells. It also acts as a brain-penetrant neutral sphingomyelinase (N-SMase) inhibitor, making it a useful tool for studying exosome biology and neuroinflammation in both in vitro and in vivo research models.

Research Area

Infectious Disease & Virology, Metabolism Research, Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number103577-45-3
MW369.361
Purity99.84% (May vary between batches)
FormulaC16H14F3N3O2S
SMILESCC1=C(CS(=O)C2=NC3=CC=CC=C3N2)N=CC=C1OCC(F)(F)F
TargetPhospholipase,Proton pump,Antibacterial
Solubility10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.41 mM);DMSO:50 mg/mL (135.37 mM)

Bioactivity

In Vivo
Lansoprazole is a potent antisecretory agent that inhibits gastric acid secretion by blocking the stomach's hydrogen/potassium adenosine triphosphatase (H+, K+-ATPase). It suppresses the upregulation of adhesion molecules in blood vessels, neutrophil activation, and the production of pro-inflammatory cytokines from activated endothelial cells. Furthermore, Lansoprazole induces the expression of various genes in gastric epithelial cells, including Phase II detoxifying enzymes (NADPH-quinone oxidoreductase, glutathione S-transferase) and antioxidative stress proteins (HO-1, thioredoxin reductase, and superoxide dismutase). In rat gastric epithelial cells, Lansoprazole upregulates HO-1 expression and exerts anti-inflammatory effects.
In Vitro
Lansoprazole significantly attenuates intestinal damage induced by ischemia-reperfusion or indomethacin. Exogenous administration of Lansoprazole can prevent injury to the small intestine caused by ischemia-reperfusion or indomethacin. Lansoprazole inhibits acute inflammatory responses and mucosal injury in rats subjected to ischemia-reperfusion or indomethacin-induced damage.

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Bacterial, A 65006, acid, A65006, A-65006, AG 1749, AG1749, AG-1749, N-SMase, inhibit, ELT, exosome, Inhibitor, gastric, HFD, Lansoprazole, TSTQ, Proton Pump, Proton pump, Protonpump, STZ, Phospholipase

Similar Products

  • 5-Hydroxylansoprazole sulfone [orb1703870]

    131927-00-9

    401.36

    C16H14F3N3O4S

    50 mg, 100 mg, 25 mg
  • Lansoprazole sulfone [orb1306737]

    >99.99% (May vary between batches)

    131926-99-3

    385.36

    C16H14F3N3O3S

    1 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 1 ml x 10 mM (in DMSO)
  • Lansoprazole sulfide [orb1705226]

    99.78% (May vary between batches)

    103577-40-8

    353.36

    C16H14F3N3OS

    1 g, 5 g, 500 mg, 10 g
  • Lansoprazole N-oxide [orb2283330]

    213476-12-1

    385.36

    C16H14F3N3O3S

    10 mg, 25 mg, 5 mg, 1 mg
  • Levolansoprazole [orb1306558]

    98.63% (May vary between batches)

    138530-95-7

    369.36

    C16H14F3N3O2S

    1 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 1 ml x 10 mM (in DMSO)
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

500 mg
$ 90.00
1 ml x 10 mM (in DMSO)
$ 90.00
1 g
$ 110.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry